Advances in magnetic resonance imaging of brain tumours
- 1 December 2003
- journal article
- neoplasms
- Published by Wolters Kluwer Health in Current Opinion in Neurology
- Vol. 16 (6) , 643-650
- https://doi.org/10.1097/00019052-200312000-00001
Abstract
Purpose of review Magnetic resonance imaging (MRI) of brain tumours provides excellent anatomical detail of brain tumours and can also reveal the biology, cellular structure and vascular dynamics of a tumour, although the use of such features in routine clinical practice has yet to be realized. In this review the latest advances in MRI of brain tumours are discussed and their clinical applications highlighted. Recent findings A large international study is underway to develop more powerful methods for automated classification of MR spectra based on the acquisition of large datasets of tumour spectra. Diffusion weighted imaging can help in the distinction between gliomas and abscesses, and perfusion weighted imaging can predict response to radiotherapy in low grade gliomas as well as distinguishing between different types of cerebral metastases. Intraoperative MRI has now been shown to be technically feasible, safe and effective in obtaining histological information as well as increasing the likelihood of complete resection for pituitary tumours and gliomas. Functional MRI and magnetic source imaging are alternative modalities that help the surgeon to avoid eloquent brain areas but may occasionally provide misleading information. Diffusion tensor imaging can demonstrate the effect of a tumour on white matter tracts and provides complementary information to that from other techniques that reveal areas of eloquent cortex. Summary Advances in MRI techniques are providing better diagnostic and therapeutic information, but can only ever be a surrogate marker of physiological and pathological processes; until it can routinely be used to image the brain at a cellular level, MRI will always be secondary to pathology in the final diagnostic evaluation.Keywords
This publication has 30 references indexed in Scilit:
- Could assessment of glioma methylene lipid resonance byin vivo1H-MRS be of clinical value?The British Journal of Radiology, 2003
- Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopyMagnetic Resonance in Medicine, 2003
- Automated classification of short echo time in in vivo 1H brain tumor spectra: A multicenter studyMagnetic Resonance in Medicine, 2002
- Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRINeuroradiology, 2002
- The potential of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis and management of patients with brain tumorsCurrent Opinion in Oncology, 2002
- The contribution of proton magnetic resonance spectroscopy ( 1 HMRS) to clinical brain tumour diagnosisBritish Journal Of Neurosurgery, 2002
- Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brainNeuroradiology, 2001
- Incidence of brain tumours in two English counties: a population based studyJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Brain abscess and necrotic or cystic brain tumor: discrimination with signal intensity on diffusion-weighted MR imaging.American Journal of Roentgenology, 1998
- Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytomaJournal of Neurosurgery, 1993